English | Español

Glaxosmithkline
Bree Gonzales | Feb 2, 2022

Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
Carol Ostrow | Dec 16, 2017

Multiple myeloma study results encouraging, GSK says
Carol Ostrow | Dec 15, 2017

GSK receives FDA approval for expanded use of Nucala
Carol Ostrow | Dec 15, 2017

GSK says Shingrix promising for preventing shingles in stem cell transplant patients
Carol Ostrow | Sep 24, 2017

GlaxoSmithKline, Innoviva COPD therapy gains FDA approval
Carol Ostrow | Sep 23, 2017

Self-injectable form of Lupus therapy clears hurdle in Europe
Carol Ostrow | Sep 21, 2017

GSK’s Shingrix shingles vaccine clears an FDA hurdle

Carol Ostrow | Sep 18, 2017

Salford Lung Study shows promise for GlaxoSmithKline asthma treatment

Trending
Patient Daily | Oct 22, 2025

Chronic Care Policy Alliance backs federal legislation to reform the 340B Drug Pricing Program
Patient Daily | Oct 23, 2025

Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues
Patient Daily | Oct 23, 2025

Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'
Patient Daily | Oct 21, 2025

Gulf Coast Breathe Free Physician Assistant on sinus issues: ‘Certain things like dairy seem to increase mucus production’